Baltimore has filed suit against kratom manufacturers and sellers, alleging violations of a local ordinance restricting the plant-based substance. The city's mayor and council assert that defendants operate with "callous disregard" for public health and safety.
Kratom, derived from the Mitragyna speciosa tree native to Southeast Asia, contains alkaloids that produce stimulant and opioid-like effects. The substance remains legal under federal law but faces increasing municipal regulation across the United States.
Baltimore's ordinance establishes restrictions on kratom sales, likely including age limits for purchasers and product labeling requirements. The city contends that sellers knowingly violate these regulations, positioning kratom as an alternative to prescription opioids despite its unregulated nature and potential for dependence.
The lawsuit targets the kratom industry's marketing practices and distribution methods within Baltimore's jurisdiction. Public health officials have raised concerns about kratom's lack of FDA approval, inconsistent alkaloid concentrations across products, and reported adverse effects including nausea, constipation, and psychological dependence.
This enforcement action reflects a broader regulatory trend. Several municipalities including San Diego, Denver, and Sarasota have implemented kratom bans or restrictions. Meanwhile, the kratom industry argues the substance offers legitimate pain management benefits and that prohibition infringes on consumer choice.
The legal question centers on municipal authority to regulate substances legal under state and federal law. Courts have generally upheld local control over commercial products when ordinances serve legitimate public health interests and survive constitutional scrutiny.
Baltimore's suit seeks compliance with the local ordinance and potential damages. The outcome will test the city's regulatory power and may influence other jurisdictions considering kratom restrictions. If successful, the case strengthens Baltimore's ability to enforce public health standards against the kratom industry.